Description
RADIOPHARMACEUTICALS DE-OBLIGATION OF EXCESS FUNDS
Base award description: RADIOPHARMACEUTICALS
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-03-22+$219,525= $219,525
- Mod P000012023-06-07+$219,525= $439,051
- Mod P000022023-09-15+$219,525= $658,576
- Mod P000032024-03-11-$101,664= $556,912
- Mod P000042024-04-12-$73,679= $483,233
- Mod P000052025-01-21-$88,999= $394,234
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-03-22 | +$219,525 | $219,525 | RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2023-06-07 | +$219,525 | $439,051 | RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2023-09-15 | +$219,525 | $658,576 | RADIOPHARMACEUTICALS |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-03-11 | −$101,664 | $556,912 | RADIOPHARMACEUTICALS DE-OBLIGATION OF EXCESS FUNDS |
| Mod P00004· FUNDING ONLY ACTION | 2024-04-12 | −$73,679 | $483,233 | RADIOPHARMACEUTICALS DE-OBLIGATION OF EXCESS FUNDS |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2025-01-21 | −$88,999 | $394,234 | RADIOPHARMACEUTICALS DE-OBLIGATION OF EXCESS FUNDS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UA3GDUKRYSM5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626P0728 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $839,629 | FY2026 |
| 36C24526N0404 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $510,182 | FY2026 |
| 36C26126N0371 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $250,075 | FY2026 |
| 36C26226N0409 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $1,561,204 | FY2026 |
| 36C26226N0410 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $752,000 | FY2026 |
| 36C25226P0239 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $303,486 | FY2026 |
Other recipients under 6505 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0367 | ISORX TEXAS LTD | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $53,945 | FY2026 |
| 36C25726N0407 | CARDINAL HEALTH 414, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,400,000 | FY2026 |
| 36C25726P0476 | PETNET SOLUTIONS, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $40,573 | FY2026 |
| 36C25726P0423 | PANHANDLE NUCLEAR RX, LTD. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $325,038 | FY2026 |
| 36C25726N0316 | PROGENICS PHARMACEUTICALS INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $721,744 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25723P0285_3600_-NONE-_-NONE- · retrieved 2026-09-26.